Cargando…
Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey
BACKGROUND: Intranasal corticosteroids (INS) are recommended as first-line therapy for allergic rhinitis. To date, no studies have evaluated the impact of an INS delivery system on patient satisfaction. Unless patients use a medication appropriately and consistently, they will not fully benefit from...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651039/ https://www.ncbi.nlm.nih.gov/pubmed/23282579 http://dx.doi.org/10.1097/WOX.0b013e3181865f99 |
_version_ | 1782269152453459968 |
---|---|
author | Fromer, Leonard M Ortiz, Gabriel R Dowdee, April M |
author_facet | Fromer, Leonard M Ortiz, Gabriel R Dowdee, April M |
author_sort | Fromer, Leonard M |
collection | PubMed |
description | BACKGROUND: Intranasal corticosteroids (INS) are recommended as first-line therapy for allergic rhinitis. To date, no studies have evaluated the impact of an INS delivery system on patient satisfaction. Unless patients use a medication appropriately and consistently, they will not fully benefit from its therapeutic effects. OBJECTIVE: To determine whether the characteristics of the mometasone furoate nasal spray (MFNS) delivery device are an impediment to its use. METHODS/DATABASE: A random sample of preidentified MFNS users was recruited through e-mail (N = 1544). In online interviews, participants were asked about MFNS ease of use and attributes. RESULTS: Ninety-eight percent of respondents reported that MFNS is easy to use, and 96% said that the applicator is easy to administer. Nearly all elderly users and users with arthritis said that the applicator fits comfortably in the nostril (96% and 97%, respectively) and is appropriately sized (97% and 96%, respectively); 96% of pediatric users agreed that the applicator fits comfortably. All users said the applicator's ease of use and comfortable fit were its most important attributes. CONCLUSIONS: The perceived ease of use of MFNS may help providers appropriately treat patients with allergic rhinitis and may improve patient adherence to INS use. |
format | Online Article Text |
id | pubmed-3651039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | World Allergy Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-36510392013-07-12 Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey Fromer, Leonard M Ortiz, Gabriel R Dowdee, April M World Allergy Organ J Original Research BACKGROUND: Intranasal corticosteroids (INS) are recommended as first-line therapy for allergic rhinitis. To date, no studies have evaluated the impact of an INS delivery system on patient satisfaction. Unless patients use a medication appropriately and consistently, they will not fully benefit from its therapeutic effects. OBJECTIVE: To determine whether the characteristics of the mometasone furoate nasal spray (MFNS) delivery device are an impediment to its use. METHODS/DATABASE: A random sample of preidentified MFNS users was recruited through e-mail (N = 1544). In online interviews, participants were asked about MFNS ease of use and attributes. RESULTS: Ninety-eight percent of respondents reported that MFNS is easy to use, and 96% said that the applicator is easy to administer. Nearly all elderly users and users with arthritis said that the applicator fits comfortably in the nostril (96% and 97%, respectively) and is appropriately sized (97% and 96%, respectively); 96% of pediatric users agreed that the applicator fits comfortably. All users said the applicator's ease of use and comfortable fit were its most important attributes. CONCLUSIONS: The perceived ease of use of MFNS may help providers appropriately treat patients with allergic rhinitis and may improve patient adherence to INS use. World Allergy Organization 2008-09-15 /pmc/articles/PMC3651039/ /pubmed/23282579 http://dx.doi.org/10.1097/WOX.0b013e3181865f99 Text en Copyright ©2008 World Allergy Organization; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Fromer, Leonard M Ortiz, Gabriel R Dowdee, April M Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey |
title | Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey |
title_full | Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey |
title_fullStr | Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey |
title_full_unstemmed | Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey |
title_short | Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey |
title_sort | assessment of patient attitudes about mometasone furoate nasal spray: the ease-of-use patient survey |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651039/ https://www.ncbi.nlm.nih.gov/pubmed/23282579 http://dx.doi.org/10.1097/WOX.0b013e3181865f99 |
work_keys_str_mv | AT fromerleonardm assessmentofpatientattitudesaboutmometasonefuroatenasalspraytheeaseofusepatientsurvey AT ortizgabrielr assessmentofpatientattitudesaboutmometasonefuroatenasalspraytheeaseofusepatientsurvey AT dowdeeaprilm assessmentofpatientattitudesaboutmometasonefuroatenasalspraytheeaseofusepatientsurvey |